Supplementary Figure S1 from A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6–Targeting Antibody–Drug Conjugate, in Patients with Small Cell Lung Cancer
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27754795
R
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
29
Citations
2
h-index
1
i10-index
Rui Li is an academic researcher from Guangzhou Women and Children Medical Center. The author has contributed to research in topics: Lung Cancer Research Studies & HER2/EGFR in Cancer Research & Lung Cancer Treatments and Mutations. The author has an h-index of 2, co-authored 17 publications.
ORCID: 0009-0001-4383-5038Papers by this author
worksSupplementary Figure S2 from A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6–Targeting Antibody–Drug Conjugate, in Patients with Small Cell Lung Cancer
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27754792
The Incidence and Clinical Characteristics of COVID‐19 in Children With IBD During the Omicron Wave: A Single‐Center Experience in China
2025 · Gastroenterology Research and Practice · 0 citations
https://doi.org/10.1155/grp/1868214
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat